The linearly decreasing convergence factor a. by Junhao Wei (6816803)

Baseline patient characteristics. by Oscar F. C. van den Bosch (22184246)

Subjects:

Overview of the six original ACTIV-3/TICO trials. by Elizabeth S. Munroe (21568166)

“…However, there is concern that by neutralizing the SARS-CoV-2 virus, nMAbs may decrease the availability of antigens to the immune system, potentially impairing the endogenous polyclonal immune response and decreasing long-term immune protection.…”

Results of dose linearity. by Masakazu Tsujimoto (22339504)

Subjects:

Linear regression analysis. by Young Kyu Lee (14076058)

Fluctuation trend of the mean temperature index. by Chengyuan Hao (21615653)

Subjects:

Variation curve of the mean temperature index. by Chengyuan Hao (21615653)

Subjects:

Mann-Kendall test for the mean temperature index. by Chengyuan Hao (21615653)

Subjects:

Boxplot mean cfPWV comparisons. by Johannes Nairz (18010746)

Subjects:

Flow chart of the study participants. by Oscar F. C. van den Bosch (22184246)

Subjects:

Effects of s-ketamine and midazolam on respiratory parameters. by Oscar F. C. van den Bosch (22184246)

Subjects:

Fig 17 - by Jianbo Jia (717814)

Changes in baseline T-cell activation markers through week 12 and week 24 according to the linear regression model. a. by Tosi M. Mwakyandile (16408705)

Differences in mean number of papers (top) and co-authors (bottom) depending on (1) NI membership and (2) time joined NI. by William C. Barley (8915282)

Subjects:

Evolution of mean values of posttraumatic stress symptomatology according to sociodemographic and occupational variables from baseline to 12-month. by Beatriz Arregui-Gallego (21553735)

Subjects:

The standard deviation of the mean total population abundance was calculated at each time step. by Cyrine Chenaoui (22177098)

Subjects:

Changes in baseline T-cell exhaustion, monocyte activation and platelet activation markers through week 12 and week 24 according to the linear regression model. a. by Tosi M. Mwakyandile (16408705)

Normalized mean difference between stimulus and responses (y axis) for a range of lags (x axis) for one average participant (p101) and one high performer (p126), separately for den... by Björn Jörges (9258411)

Subjects:

The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin... by Chanel Avenant (409756)

“…Both contraceptives substantially decreased, from D0 to 25W, the total testosterone [DMPA-IM D0 0.560, 25W 0.423 nmol/L, -24.3% (p < 0.0001); NET-EN D0 0.551, 25W 0.253 nmol/L, -54.1%, (p < 0.0001)], SHBG [DMPA-IM D0 45.0, 25W 32.7 nmol/L, -29.8% (p < 0.0001); NET-EN D0 50.2, 25W 17.6 nmol/L, -65.1% (p < 0.0001)], and calculated free testosterone levels [DMPA-IM D0 6.87, 25W 5.38 pmol/L, -17.2% (p = 0.0371); NET-EN D0 6.00, 25W 3.70, -40.0% (p < 0.0001)]. …”

Participants characteristics. by Sakiko Fukui (387048)